|
|||||
|
|
Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study |
|
| Authors: | Xiaoyan Ding MD Wei Sun MD Wei Li MD PhD Yanjun Shen MD Xiaodi Guo MD Ying Teng MD Xiaomin Liu MD Linlin Zheng PhD Wendong Li MD Jinglong Chen MD |
| Affiliation: | 1. Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China;2. Jinan Eco-environmental Monitoring Center of Shandong Province, Shandong, China |
| Abstract: | |
| Keywords: | hepatocellular carcinoma lenvatinib portal vein thrombosis sorafenib transarterial chemoembolization |